Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

Immunoglobulin light-chain (AL) amyloidosis is a rare, incurable plasma cell disorder. Its therapy has benefited immensely from the expanding drug armamentarium available for multiple myeloma. Pomalidomide in combination with weekly dexamethasone (Pom/dex) is active among patients with relapsed myel...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Dispenzieri, Angela, Buadi, Francis, Laumann, Kristina, LaPlant, Betsy, Hayman, Suzanne R., Kumar, Shaji K., Dingli, David, Zeldenrust, Steven R., Mikhael, Joseph R., Hall, Robert, Rajkumar, S. Vincent, Reeder, Craig, Fonseca, Rafael, Bergsagel, P. Lief, Stewart, A. Keith, Roy, Vivek, Witzig, Thomas E., Lust, John A., Russell, Stephen J., Gertz, Morie A., Lacy, Martha Q.
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2012
主題:
Clinical Trials and Observations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369677/
https://ncbi.nlm.nih.gov/pubmed/22493299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-413161
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍